NCT04467853View on ClinicalTrials.gov

A Clinical Study to Evaluate CAR-T Cell-based Medicinal Product in the Treatment of Advanced Solid Tumors

PHASE1TerminatedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

September 21, 2020

Primary Completion Date

July 17, 2023

Study Completion Date

July 17, 2023

Conditions
Solid Tumors, Adult
Interventions
BIOLOGICAL

LCAR-C18S cells

Before treatment with LCAR-C18S cells, subjects will receive a conditioning regimen

Trial Locations (3)

200126

Shanghai East Hospital, Shanghai

Unknown

Anhui Provincial Hospital, Hefei

Shanghai Artemed Hospital, Shanghai

Sponsors
All Listed Sponsors
collaborator

Nanjing Legend Biotech Co.

INDUSTRY

lead

Shanghai East Hospital

OTHER